Continuous high dosing of lenalidomide in relapsed, refractory or older newly diagnosed acute myeloid leukemia patients not suitable for other treatment options - results from a phase I study
Related Research units
Bibliographical data
| Original language | English |
|---|---|
| ISSN | 0390-6078 |
| DOIs | |
| Publication status | Published - 02.2019 |
Comment Deanary
Letter to the Editor
| PubMed | 30171028 |
|---|
